Temporalmente, el archivo digital asociado a esta publicación, no se encuentra disponible. Para más información escribir a repositorio@uss.cl
Este documento se encuentra disponible en su fuente de origen, si desea acceder al texto completo, puedes hacerlo a continuación:
Autor(es)
Francisca, Stolzenbach; Gloria, Alarcón Fernández; Marco, Pérez Bustamante; Camila, Navia Casanova; Víctor, Cortés; Bredford, Kerr |
ISSN:
0925-4439 |
Idioma:
eng |
Fecha:
2024-08 |
Tipo:
Artículo |
Revista:
Biochimica et Biophysica Acta - Molecular Basis of Disease |
Datos de la publicación:
vol. 1870 Issue: no. 6 Pages: |
DOI:
10.1016/j.bbadis.2024.167258 |
Descripción:
Publisher Copyright: © 2024 |
Resumen:
The increasing prevalence of obesity, type 2 diabetes mellitus (T2DM), and gestational diabetes (GDM) among pregnant women has risen dramatically worldwide. The antihyperglycemic drug metformin is the most common drug for T2DM treatment in non-pregnant individuals; nevertheless, it is increasingly being used for diabetes-complicated pregnancies. Studies on the long-term metabolic effects of this drug in offspring remain scarce. This work aimed to determine the effect of metformin exposure during pregnancy and lactation on the offspring of a model of diet-induced maternal hyperglycemia. Cohorts of pregnant mice were fed a 46% fat diet (HFD) or a control standard diet (SD). A group of dams were exposed to metformin during pregnancy and lactation. After weaning, the offspring were fed SD for 8 weeks and then challenged with a 46% HFD after puberty for 12 weeks. Irrespective of the maternal diet, offspring of metformin-exposed mothers had a lower body weight and reduced inguinal white adipose tissue (iWAT) mass after HFD challenge. This was associated with increased expression of Pparg, Fabp4, Glut4, Srebp1, and Fasn in the iWAT during adulthood in the metabolically impaired dams exposed to metformin, suggesting increased adipogenesis and de novo lipogenesis. Increased expression of Fasn associated with decreased methylation levels at its promoter and proximal coding region in the iWAT was found. These results suggest that metformin modulates gene expression levels by epigenetic mechanisms in maternal metabolic-impaired conditions. The increasing prevalence of obesity, type 2 diabetes mellitus (T2DM), and gestational diabetes (GDM) among pregnant women has risen dramatically worldwide. The antihyperglycemic drug metformin is the most common drug for T2DM treatment in non-pregnant individuals; nevertheless, it is increasingly being used for diabetes-complicated pregnancies. Studies on the long-term metabolic effects of this drug in offspring remain scarce. This work aimed to determine the effect of metformin exposure during pregnancy and lactation on the offspring of a model of diet-induced maternal hyperglycemia. Cohorts of pregnant mice were fed a 46% fat diet (HFD) or a control standard diet (SD). A group of dams were exposed to metformin during pregnancy and lactation. After weaning, the offspring were fed SD for 8 weeks and then challenged with a 46% HFD after puberty for 12 weeks. Irrespective of the maternal diet, offspring of metformin-exposed mothers had a lower body weight and reduced inguinal white adipose tissue (iWAT) mass after HFD challenge. This was associated with increased expression of Pparg, Fabp4, Glut4, Srebp1, and Fasn in the iWAT during adulthood in the metabolically impaired dams exposed to metformin, suggesting increased adipogenesis and de novo lipogenesis. Increased expression of Fasn associated with decreased methylation levels at its promoter and proximal coding region in the iWAT was found. These results suggest that metformin modulates gene expression levels by epigenetic mechanisms in maternal metabolic-impaired conditions. |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |
El Repositorio Institucional de la Universidad San Sebastián reúne los trabajos académicos y de investigación elaborados por la comunidad universitaria. Contribuye a la visibilidad y difusión, para ser consultados a través de acceso abierto por toda la comunidad nacional e internacional.
El objetivo del Repositorio es almacenar, conservar y entregar en formato electrónico, los resultados del quehacer institucional, permitiendo mayor visibilidad y difusión por medio del acceso abierto y gratuito.